AU2022369065A1 - Peptides with multivalent effects - Google Patents

Peptides with multivalent effects Download PDF

Info

Publication number
AU2022369065A1
AU2022369065A1 AU2022369065A AU2022369065A AU2022369065A1 AU 2022369065 A1 AU2022369065 A1 AU 2022369065A1 AU 2022369065 A AU2022369065 A AU 2022369065A AU 2022369065 A AU2022369065 A AU 2022369065A AU 2022369065 A1 AU2022369065 A1 AU 2022369065A1
Authority
AU
Australia
Prior art keywords
amino acids
peptide
seq
peptides
peptide according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022369065A
Other languages
English (en)
Inventor
Ganna PETRUK
Artur Schmidtchen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IN2CURE AB
Original Assignee
IN2CURE AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IN2CURE AB filed Critical IN2CURE AB
Publication of AU2022369065A1 publication Critical patent/AU2022369065A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2022369065A 2021-10-22 2022-10-21 Peptides with multivalent effects Pending AU2022369065A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21204274.1 2021-10-22
EP21204274 2021-10-22
PCT/EP2022/079429 WO2023067167A1 (en) 2021-10-22 2022-10-21 Peptides with multivalent effects

Publications (1)

Publication Number Publication Date
AU2022369065A1 true AU2022369065A1 (en) 2024-04-11

Family

ID=78592450

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022369065A Pending AU2022369065A1 (en) 2021-10-22 2022-10-21 Peptides with multivalent effects

Country Status (7)

Country Link
US (1) US20250313820A1 (https=)
EP (1) EP4419664A1 (https=)
JP (1) JP2024539138A (https=)
CN (1) CN118202043A (https=)
AU (1) AU2022369065A1 (https=)
CA (1) CA3233135A1 (https=)
WO (1) WO2023067167A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024223868A1 (en) * 2023-04-26 2024-10-31 In2Cure Ab Peptides with multivalent effects for topical use
WO2025051955A1 (en) 2023-09-06 2025-03-13 In2Cure Ab Materials with anti-inflammatory and/or anti-microbial properties

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1987056B1 (en) * 2006-02-10 2012-07-25 Dermagen AB Novel antimicrobial peptides and use thereof
GB0916576D0 (en) * 2009-09-22 2009-10-28 Malmsten Nils M Polypeptides and uses thereof
AU2018304230A1 (en) 2017-07-19 2020-02-06 Dana-Farber Cancer Institute, Inc. Stabilized anti-microbial peptides for the treatment of antibiotic-resistant bacterial infections
JP7785001B2 (ja) * 2019-12-18 2025-12-12 イントゥーキュア エービー トロンビン由来ペプチドを含む組成物およびその使用

Also Published As

Publication number Publication date
US20250313820A1 (en) 2025-10-09
JP2024539138A (ja) 2024-10-28
WO2023067167A1 (en) 2023-04-27
CN118202043A (zh) 2024-06-14
CA3233135A1 (en) 2023-04-27
EP4419664A1 (en) 2024-08-28

Similar Documents

Publication Publication Date Title
RU2468033C2 (ru) Антибактериальные пептиды
KR102137941B1 (ko) 항균 펩티드
Panjla et al. Short peptides and their mimetics as potent antibacterial agents and antibiotic adjuvants
KR102499670B1 (ko) 라이신 치환을 포함하는 Romo1 유래 항균 펩타이드 및 그 변이체
US20250313820A1 (en) Peptides with multivalent effects
WO2011036443A2 (en) Polypeptides and uses thereof
Cui et al. Preparation, characterization and pharmacokinetic study of N-terminal PEGylated D-form antimicrobial peptide OM19r-8
Li et al. Improving selectivity, proteolytic stability, and antitumor activity of Hymenochirin-1B: A novel glycosylated staple strategy
Cárdenas-Martínez et al. Effects of substituting arginine by lysine in bovine lactoferricin derived peptides: pursuing production lower costs, lower hemolysis, and sustained antimicrobial activity
WO2025208807A1 (zh) 一种抗菌肽Thanatin衍生肽及其医药用途
WO2022171098A1 (zh) 一种dapk1磷酸化底物的人工小分子干扰肽及其制药用途
Shang et al. Engineered peptides harboring cation motifs against multidrug-resistant bacteria
CN115803338A (zh) C型利尿钠肽及其治疗急性肺损伤的方法
Okubo et al. Precision engineered peptide targeting leukocyte extracellular traps mitigate acute kidney injury in Crush syndrome
JP4812347B2 (ja) 抗菌性ペプチド
TWI740034B (zh) 治療癌症之肽
JP2018508580A (ja) ペグ化ｉｌ−１１の組成物および方法
CN108752433B (zh) 抗微生物肽cramp及其环肽在制备清除细菌生物膜的药物中的应用
WO2019085926A1 (zh) 多黏菌素类似物及其制备方法
WO2011060018A2 (en) Compositions and methods for using peptides, modified peptides, peptidomimetics and fibrin derivatives
WO2008104777A2 (en) Peptide
EP3665190A1 (en) Disintegrin variants and uses thereof
Porta et al. Myotoxin a, crotamine and defensin homologs in reptile venoms
US20250101062A1 (en) Antimicrobial peptides
CN106674329A (zh) 具备抗微生物、抗癌/促进伤口愈合活性的肽及其用途